Keywords: abbott, 2nd-qtr, sales, rise, usa-based, drug, major
Abbott's 2nd-qtr 2004 sales rise 14%
Article | 19 July 2004
USA-based drug major Abbott Laboratories saw its sales rise 14% to $4.7billion for the second quarter of 2004 from $4.1 billion for like, ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
- Elan makes "transformational" acquisitions and a divestment
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- CIS countries prepare for the introduction of drug reimbursement schemes
- Greek research-based drugmaker group AIFD challenges generics assumptions in Draft Patent Law
